Cydectin TriclaMox 1 mg/ml + 50 mg/ml Oral Solution for Sheep

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Moxidectin, Triclabendazole

Available from:

Zoetis UK Limited

ATC code:

QP54AB52

INN (International Name):

Moxidectin, Triclabendazole

Pharmaceutical form:

Oral solution

Prescription type:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Therapeutic group:

Sheep

Therapeutic area:

Endectocide

Authorization status:

Authorized

Authorization date:

2009-12-18

Summary of Product characteristics

Revised: September 2023
AN: 02189/2022
Page 1 of 8
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cydectin TriclaMox 1mg/ml + 50 mg/ml Oral Solution for Sheep
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCES
Moxidectin
1.0 mg
Triclabendazole
50.0 mg
EXCIPIENTS
Benzyl alcohol (E1519)
40.0 mg
Butylhydroxytoluene (E321) 1.0 mg
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Oral solution
A clear yellow to brown liquid
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of mixed nematode and fluke infections, caused by
moxidectin and
triclabendazole sensitive strains of:
Revised: September 2023
AN: 02189/2022
Page 2 of 8
Parasite
ADULT STAGE
L4
INHIBITED
STAGES
NEMATODES
GASTRO-INTESTINAL
NEMATODES:
_Haemonchus contortus_



_Teladorsagia circumcincta_



_Ostertagia trifurcata_


_Trichostrongylus axei_



_Trichostrongylus _
_colubriformis_


_Trichostrongylus vitrinus_


_Nematodirus battus_


_Nematodirus spathiger_


_Nematodirus filicolis_

_Strongyloides papillosus_

_Cooperia curticei_

_Cooperia oncophora_


_Oesophagostomum _
_columbianum_


_Oesophagostomum _
_venulosum_

_Chabertia ovina_


_Trichuris ovis_

RESPIRATORY TRACT
NEMATODE:
_Dictyocaulus filaria_

TREMATODES
LIVER FLUKE:
ADULT STAGE
EARLY IMMATURE
STAGES
LATE IMMATURE
STAGES
_Fasciola hepatica_



The product has a persistent efficacy and protects sheep against
infection or re-
infection with the following parasites for the period indicated:
SPECIES
PROTECTION PERIOD (DAYS)
_Teladorsagia circumcincta_
35
_Haemonchus contortus_
35
Clinical trials, after experimental and natural infection, have shown
that the product is
effective against certain benzimidazole resistant strains of:
._ Haemonchus contortus_
_. Teladorsagia circumcincta_
_. Trichostrongylus colubriformis_
_. Cooperia curticei_